Centrum Onkologii Ziemi Lubelskiej

Lublin, Lublin Voivodeship 20-090

1 studies enrolling now · 4 studies all time

What they study most

Chronic Lymphocytic Leukemia, Follicular Lymphoma, Lymphoma, Mantle-Cell, Relapsed or Refractory Multiple Myeloma (RRMM), Small Lymphocytic Lymphoma

Studies at this site

• A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) — Recruiting now
• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed